A batch of non-basic drugs is restricted

1.
There are also hospitals that restrict the use of non-basic drugs

1.
There are also hospitals that restrict the use of non-basic drugs

Recently, the industry has circulated a "Notice on Soliciting the Demand for National-based Products in 2021" issued by the People's Hospital of a certain district, which further stipulates the requirements for the hospital's national-based varieties in 2021
.

According to the document, in accordance with the requirements of the “Notice of the Office of the Guangdong Provincial Health Commission on Printing and Distributing the Key Points of Drug Administration in 2021” (Yueweiban Yaozheng Han [2021] No.
2), we will strive to purchase essential drugs for public hospitals at all levels by the end of this year.
The growth rate of the proportion of the number has reached more than 6%
.

According to the requirements of secondary public medical institutions, the proportion of national-based products purchased by the hospital should not be less than 56%.

In order to cooperate with the policy of giving priority to the use of national essential medicines, we are now collecting national-based specialty medicine requirements from clinical departments:

1.
Only limited to the national essential medicines within the scope of the medical insurance catalog (according to the 2018 National Essential Drug Catalog), and it is required to be able to purchase online
.

2.
All specialties apply for medicines for the specialty medicines, and cross-professional applications are strictly prohibited
.

3.
National-based applications for antibacterial drugs must eliminate non-based antibacterial drugs, and only apply for key use departments of antibacterial drugs, such as the Infectious Diseases Department, Respiratory Department, and ICU
.

4.
State-based patent applications for Chinese patent medicines need to eliminate non-basic Chinese patent medicines with similar ingredients and efficacy
.

5.
If the application department is within the scope of specialty, non-national-based varieties can be eliminated, and national-based varieties with the same or similar pharmacological effects can be applied for change
.

Accept non-basic country-base change applications with the same common name

It is reported that each department can submit no more than 2 (including 2) application reports
.

The application department should be based on the needs of clinical and specialty development, and the department director shall organize a department management group meeting for collective discussion and decision, and make a record of the meeting discussion for future reference

According to the data, the hospital is a comprehensive hospital integrating medical treatment, prevention, health care, teaching, and scientific research.
It was rated as a national second-class hospital in 1993, and it is the first batch of medical insurance designated hospitals in Guangdong Province; the whole hospital There are more than ten clinical departments including internal medicine, surgery, obstetrics and gynecology, pediatrics, ENT, dentistry, emergency department, outpatient department and other medical technology auxiliary departments such as imaging center and laboratory department.
In 2008, the number of outpatient visits was 780,200.
21,700 people were discharged from hospital
.

2.
Many hospitals are restricting non-basic drugs

2.
Many hospitals are restricting non-basic drugs

Judging from the contents of the above-mentioned documents, hospitals are trying to restrict the use of non-basic drugs through the demand application of national-based products, and this has been a common occurrence in Guangdong Province in recent years
.

The main reason is that Guangdong Province has specifically put forward requirements for the proportion of essential medicines: the proportion of basic medicines purchased from basic to tertiary hospitals has increased to 60%, 50%, and 40%, and the proportion of the amount used has increased to 50%.
, 40%, 30%
.

Guangdong also proposed that medical institutions will not evaluate the best if the ratio of basic medicines is not up to standard for two consecutive years

In December 2020, a tertiary grade A hospital in Guangdong Province required: Within the scope of the specialty, if the variety in use is non-National-based, it can be replaced by an application to change the national-based variety with the same generic name
.

There is a view in the industry that the hospital has moved from 31.

In October of the same year, a tertiary hospital directly limited the use of non-basic drugs: auxiliary drugs, the city’s key monitoring drug catalog (2018 edition), with a monthly limit of 10,000 yuan per product specification; a monthly limit of 20,000 yuan for therapeutic drugs and antibacterial drugs.
The product regulations will be temporarily suspended when used up in the current month
.

At the same time, in September, a hospital in Guangdong Province implemented quota procurement for the top single-variety non-basic medicines according to the amount of money used, of which the quota of non-national basic medicines was 40,000 yuan

At the national level, regulations on the use of essential medicines are gradually becoming clear, and the most direct is the 986 policy
.

According to the relevant documents of the General Office of the State Council, hospitals at all levels are required to be equipped with basic medicines: 90% for primary care, 80% for secondary hospitals, and 60% for tertiary hospitals

At the April National Pharmaceutical Policy Work Conference, relevant leaders pointed out: All localities must fully understand the functional positioning of essential drugs in ensuring clinical necessity, and promote medical institutions at all levels and various types to accelerate the establishment of a "1+X" clinical drug model, and steadily expand Clinical use of essential drugs
.

However, it is worth noting that there is still a gap between the proportion of basic medicines in hospitals at all levels across the country and the target.
On March 30, the National Health Commission announced the results of the performance appraisal of the national tertiary public hospitals, although the basic medicine The number of drugs purchased has increased, but it has not reached the 60% requirement
.

3.
The adjustment of the basic medicine catalog is coming soon

3.
The adjustment of the basic medicine catalog is coming soon

According to the random inspection data of the proportion of basic medicines in medical institutions nationwide in 2019, the proportions of primary, secondary, and tertiary medical institutions are 59%, 45%, and 39%, respectively, which are far below the required 90%, 80%, and 60%
.

According to the hospital drug management regulations, the number of product specifications for the top three hospitals equipped with drugs is about 1,500

Therefore, according to the requirement that the annual compound growth rate is not less than 4%, the annual introduction of basic medicines in the top three hospitals must reach 60 varieties to meet the standards.
This is mainly achieved by excluding existing non-basic medicines, introducing basic medicines, and replacing existing non-basic medicines.
Medicine varieties
.
If the base drugs are equipped in strict accordance with the requirements, the sales of non-basic drugs will inevitably appear to decline
.

Nowadays, these non-basic medicines have ushered in new opportunities.
This year is a critical period for the adjustment of the basic medicine catalog.
According to the spirit of the meeting, the 3-year cycle of catalog adjustment remains unchanged, but there will be small adjustments every year.
2018 On October 25, 2010, the National Health Commission released the latest version of the National Essential Medicines List (2018 Edition).
According to a three-year adjustment cycle, the release of the 2021 Essential Medicines List has become a high probability event
.

According to the industry, 270 new types of basic medicines are expected to be added this time, including 130 types of chemical medicines and 140 types of Chinese patent medicines.
This means that a batch of non-basic medicines has ushered in new opportunities for increased volume
.